EXOR NV will increase its stake in BIOMERIEUX to 8.53% from 3.87% through an asset exchange. The transaction positions the investment firm as a long-term shareholder in the France-based diagnostics maker. Italy's Agnelli family controls the investment company, which holds a 10% stake in BIOMERIEUX's parent.

Transaction Structure and Shareholding Changes